Dual purpose universal influenza vaccine confers protective immunity against anthrax
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 6, 2019
Grant Date -
Sep 7, 2017
app pub date -
Mar 1, 2017
filing date -
Mar 1, 2016
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention includes antigenic fusion proteins, nucleic acids encoding the fusion proteins and methods of making and using the same, wherein the fusion protein comprises three or more different influenza A ectodomains of Matrix Protein 2 (M2e); one or more stem regions of an influenza A hemagglutinin 2 (HA2) protein; and optionally an anthrax antigen, wherein the fusion protein is immunogenic across strains.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully